31
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Ten and Ninety-Day Toxicity Studies of chloropicrin in Sprague-Dawley Rats

, , &
Pages 125-137 | Published online: 27 Sep 2008
 

ABSTRACT

The toxicity of chloropicrin (CP) was assessed following its administration to rats via oral gavage for either 10 or 90 consecutive days at dose levels of 10, 20, 40, and 80 mg/kg and 2,8 and 32 mg/kg, respectively. Control rats received corn oil at a dose of 1.0 ml/kg. Toxicological observations included organ and body weight measurements, necropsy and histopathology observations, urinalysis, clinical chemistry and hematology determinations. The most remarkable toxicological finding in both studies was the corrosive property of CP on forestomach tissue. Inflammation, necrosis, acantholysis, hyperkeratosis and epithelial hyperplasia of the forestomach were seen in all dose groups of the 10-day study. Similar changes were detected in only the high dose group in the 90-day study. Decreased red blood cell parameters were noted in the highest dose groups in both studies, possibly due to blood loss via the damaged stomach lining. CP may have been aspirated into the lungs of animals in the high dose group in the ninety day study resulting in pulmonary complications leading to the deaths of 60% of the males and 80% of the females starting at week five. The 8 mg/kg dose group in the ninety day study was considered to be the no observed adverse effect level.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.